Japan nod for Efient in ischemic heart disease
This article was originally published in Scrip
Executive Summary
Daiichi Sankyo's Efient (prasugrel) has been approved in Japan for use in patients with ischemic heart disease undergoing percutaneous coronary intervention (PCI).